Introduction
Biodegradable polymeric stents represent a potential alternative to permanent metal stents, but to date, human experience with such devices is limited. The aim of this study is to assess the in vivo biocompatibility of a novel biodegradable stent based on poly(L-lactide) (PLLA) and poly(4-hydroxybutyrate) (P4HB) for peripheral vascular application.
Methods
Biodegradable polymeric stents (PLLA/P4HB) and permanent bare-metal stents (316L) were implanted interventionally into both common carotid arteries (CCA) of 6 female pigs via the left common iliac artery (8F-sheath). The stents were mounted on a balloon catheter (5.0x40 mm), and balloon-expanded with either 8 bar (PLLA/P4HB) or 9 bar (316L). The pigs were administered peroral aspirin (100 mg) and clopidogrel (75 mg) starting 5 days before the procedure until the end of the study. Stented CCA segments were explanted after 4 weeks, and processed for quantitative histomorphometry, and estimation of vascular inflammation and injury scores.
Results
All animals survived until the end of the study without developing neurological complications. In both study groups all stents were patent on histological analysis without any signs of excessive recoiling or collapse. The PLLA/P4HB stents showed a decreased residual lumen area and higher restenosis after 4 weeks (6.72 mm² ± 0.69 and 37.75% ± 6.35) as compared to the 316L reference stents (15.06 mm² ± 2.97 and 8.89 % ± 2.35). After 4 weeks, inflammation score were higher in PLLA/P4HB group (0.95 ± 0.45) compared to the 316L group (0.55 ± 0.16). In contrast, the 316L stents showed a higher vascular injury score (0.87 ± 0.19) compared to the PLLA/P4HB stents (0.41 ± 0.19).
Conclusion
The higher restenosis rate of polymeric stents in this study deserves further research, but was in accordance with our previous results of an invasive surgical animal model. Development of a drug-eluting polymeric stent will be a feasible approach to improve vascular response.
